Cesarean section in a patient with Ebstein’s anomaly: A multidisciplinary approach to high-risk obstetric management

Authors

  • Javier Edmundo Herrera Villalobos Hospital Materno Infantil ISSEM y M https://orcid.org/0000-0001-6252-1563
  • Berenice Almeida Gonzalez Romero Hospital Materno Infantil ISSEM y M

Keywords:

cardio-obstetrics, heart failure, high risk pregnancy

Abstract

We present the case of a 37-year-old woman with Ebstein’s anomaly and a prior tricuspid valve replacement. At 38.2 weeks of gestation, she underwent an elective cesarean delivery without complications. We propose a schematic representation of a standardized workflow system for pregnant women with heart disease in obstetric critical care units. Ebstein’s anomaly is a rare congenital heart defect, with a prevalence of less than 0.3%, and limited evidence regarding its prognosis during pregnancy. Management requires a multidisciplinary approach, with primary emphasis on controlling heart failure. Implementation of the proposed workflow reduces indirect maternal mortality. Systematizing evidence-based interventions minimizes human error in complex scenarios and transforms empirical management into a protocol-driven strategy that ensures maternal and fetal safety.

Downloads

Download data is not yet available.

References

Khalid H, Karishma F, Mumtaz H, Saqib M, Iftikhar M, Shahab R. Current status and future of cardio-obstetrics-review. Ann Med Surg (Lond). 2023;85(6):2774-2780. doi:10.1097/MS9.0000000000000773.

Davis et al. Cardio-Obstetrics Part 1/5. JACC Vol.77, No. 14, (2021) 13: 1763-77 How to cite this article: Davis, M, Arendt, K, Bello, N, Brown H, Briller J, Eppset K, et. al. Team-Based care of women with cardiovascular disease from pre-conception through pregnancy and postpartum. J Am Coll Cardiol. 2021;77(14):1763–1777. doi:10.1016/j.jacc.2021.02.03.

Díaz-Antóna B, Villar-Ruíz O, Granda-Nistal C, Martín-Asenjo R, Jiménez-López-Guarch C, Escribano-Subiasa P. Embarazo en mujeres con cardiopatía estructural: experiencia de un centro. Rev Esp Cardiol. 2015;68(12):1189-1190. doi:10.1016/j.recesp.2015.08.013.

Sliwa K, Petrie MC, van der Meer P, Mebazaa A, Hilfiker-Kleiner D, Jackson AM, et al. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J. 2020;41(39):3787-3797. doi:10.1093/eurheartj/ehaa455.

Clapp MA, Bernstein SN. Preconception Counseling for Women With Cardiac Disease. Curr Treat Options Cardiovasc Med. 2017 Sep;19(9):67. doi: 10.1007/s11936-017-0565-z.

Berliner D, Li T, Mariani S, Hamdan R, Hanke J, König T, et al. Clinical characteristics and long-term outcomes in patients with peripartum cardiomyopathy (PPCM) receiving left ventricular assist devices (LVAD). Artif Organs. 2023;47(2):417-424. doi: 10.1111/aor.14406.

Viljoen, C ∙ Hoevelmann, J ∙ Sliwa, K Peripartum cardiomyopathy: risk factors and predictors of outcome. Curr Opin Cardiol. 2023;38(3):223-232. doi:10.1097/HCO.0000000000001037.

Carranza-Cortés JL, Espinosa-Valencia DJ. Mediciones hemodinámicas de la preeclampsia severa/eclampsia: ¿Es determinante su aportación para aplicar maniobras terapéuticas? Rev Arg Anest. 2005:3-10.

Jackson AM, Macartney M, Brooksbank K, Brown C, Dawson D, Francis M, et al. A 20-year population study of peripartum cardiomyopathy. Eur Heart J. 2023;44(48):5128-5141. doi:10.1093/eurheartj/ehad626.

Sliwa K, van der Meer P, Petrie MC, Frogoudaki A, Johnson MR, Hilfiker-Kleiner D, et al. Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2021; 23(4):527-540. doi:10.1002/ejhf.2133.

Suriya JY, Raj A, Pillai AA, Satheesh S, Plakkal N, Kundra P, et al. Ebstein’s anomaly during pregnancy: experience from a tertiary care centre - a case series and review of literature. J Obstet Gynaecol. 2022;42(4):594-596. doi:10.1080/01443615.2021.1932777.

Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455-463. doi:10.1093/ije/dyz009.

van der Zande JA, Tutarel O, Ramlakhan KP, van der Bosch AE, Bordese R, Zengin E, et al. Pregnancy outcomes in women with Ebstein’s anomaly: data from the Registry of Pregnancy And Cardiac disease (ROPAC). Open Heart. 2023;10(2):e002406. doi:10.1136/openhrt-2023-002406.

Ruys TP, Roos-Hesselink JW, Pijuan-Domènech A, Vasario E, Gaisin IR, Iung B, et al. Is a planned caesarean section in women with cardiac disease beneficial? Heart. 2015;101(7):530-6. doi:10.1136/heartjnl-2014-306497.

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e876-e894. doi:10.1161/CIR.0000000000001062.

Published

2026-02-27

How to Cite

1.
Herrera Villalobos JE, Gonzalez Romero BA. Cesarean section in a patient with Ebstein’s anomaly: A multidisciplinary approach to high-risk obstetric management. CorSalud [Internet]. 2026 Feb. 27 [cited 2026 Mar. 1];18(1):e1268. Available from: https://revcorsalud.sld.cu/index.php/cors/article/view/1268